Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

USANA Health Sciences, Inc. USNA

Consumer Defensive  —  Packaged Foods
14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

 31.31 35.69 37.17 0.00
P/S ratio 0.55 0.39 0.35 0.43
P/FCF ratio 26.96 29.27 46.49 19.83
P/Operating CF (257.00) (107.33) 32.94 16.93
P/B ratio 0.95 0.68 0.59 0.75
Price to Tangible BV 2.05 1.39 1.16 1.35
EV/Sales 0.40 0.23 0.18 0.26
EV/EBITDA 4.74 2.75 2.21 3.48
EV/Operating CF 11.59 9.50 9.96 8.40
EV/FCF 19.55 17.08 23.94 11.71
Quick Ratio 1.22 1.27 1.47 1.63
Current Ratio 2.23 2.24 2.51 2.66
Net Debt/EBITDA (13.47) (11.23) (6.88) (9.21)
Debt/Assets 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00
Asset Turnover 1.31 1.24 1.25 1.27
Operating CF/Net income 0.30 1.91 1.30 (1.09)
Capex/Depreciation (0.33) 0.11 (0.27) (0.08)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 76.58% 73.39% 70.70% 74.26%
Intangible Assets out of Total Assets 0.39 0.36 0.36 0.33
Share Based Compensation of Revenue 1.67% 1.66% 1.38% 1.52%
Graham Net Nets 0.13 0.22 0.31 0.26
Graham Number 23.91 18.87 17.68 0.00
Earnings Yield 3.19% 2.80% 2.69% (5.67%)
Free Cash Flow Yield 3.71% 3.42% 2.15% 5.04%
Revenue per Share 11.68 12.20 13.60 12.08
Operating CF per Share (0.11) (0.18) 0.53 1.26
Capex per Share (0.17) 0.06 (0.14) (0.17)
Free Cash Flow per Share (0.28) (0.12) 0.39 1.09
Cash per Share 7.95 8.54 8.85 9.12
Shareholders Equity per Share 28.87 28.76 29.54 28.47
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 28.87 28.76 29.54 28.47
Free Cash Flow (5.16) (2.28) 7.16 20.18
Working Capital 145.40 159.84 176.99 175.39
Capital Expenditures (3.20) 1.11 (2.60) (3.14)
Net Current Asset Value 65.55 78.59 98.82 104.16
EV/EBIT 8.74 5.67 4.65 0.00
Capex to Sales 0.02 0.00 0.01 0.01
Net Profit Margin (3.05%) (0.78%) 3.00% (9.58%)
Price to Operating Income 12.05 9.72 9.02 0.00
Other line items
Average Receivables — 6.52 8.54 5.25
Average Payables 11.63 14.62 15.10 16.67
Average Inventory 77.38 86.17 84.96 84.81
Average Assets 698.95 745.55 742.78 718.87
Average Common Equity 530.58 532.61 536.66 528.68

Fold the line items

Columns are period end dates